Shopping Cart
Remove All
Your shopping cart is currently empty
OTUB1/USP8-IN-1 HCl
😃Good
Catalog No. T72784L
Alias OTUB1/USP8-IN-1 HCl(2858800-98-1 Free base)
OTUB1/USP8-IN-1 HCL is a potent dual inhibitor of OTUB1 and USP8 with potential antitumour activity, inhibiting both OTUB1 and USP8. OTUB1/USP8-IN-1 may be used in the study of leukaemia.
OTUB1/USP8-IN-1 HCl
😃Good
Purity: 99.92%
Catalog No. T72784LAlias OTUB1/USP8-IN-1 HCl(2858800-98-1 Free base)
OTUB1/USP8-IN-1 HCL is a potent dual inhibitor of OTUB1 and USP8 with potential antitumour activity, inhibiting both OTUB1 and USP8. OTUB1/USP8-IN-1 may be used in the study of leukaemia.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $162 | Inquiry | Inquiry | |
| 5 mg | $357 | Inquiry | Inquiry | |
| 10 mg | $429 | Inquiry | Inquiry | |
| 25 mg | $987 | Inquiry | Inquiry | |
| 50 mg | $1,520 | Inquiry | Inquiry | |
| 100 mg | $1,980 | Inquiry | Inquiry |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products. However, due to objective factors, there is a small probability that the synthesis may not be successful during the R&D process. We appreciate your understanding. If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
Batch Information
Select Batch
Purity:99.92%
ee:100%
Appearance:Solid
Color:Yellow
Contact us for more batch information
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | OTUB1/USP8-IN-1 HCL is a potent dual inhibitor of OTUB1 and USP8 with potential antitumour activity, inhibiting both OTUB1 and USP8. OTUB1/USP8-IN-1 may be used in the study of leukaemia. |
| Targets&IC50 | OTUB1:0.17 nM, USP8:0.28 nM |
| In vitro | OTUB1/USP8-IN-1 (compound 61) exhibits antiproliferative effects in KRAS-WT (H1975, EBC-1, H1703) and KRAS-mutated (H23, A549) NSCLC cell lines when treated with concentrations ranging from 10 nM to 10 μM for 72 hours[1]. Additionally, treatment with OTUB1/USP8-IN-1 at 500 nM for 24 hours leads to a decrease in protein levels of both UBE2N and EGFR in H1975 cells[1]. |
| In vivo | In the H1975 xenograft mouse model, treatment with OTUB1/USP8-IN-1 (compound 61) at concentrations ranging from 10 nM to 10 μM for 72 hours results in a decrease in tumor burden[1]. |
| Synonyms | OTUB1/USP8-IN-1 HCl(2858800-98-1 Free base) |
| Molecular Weight | 463.29 |
| Formula | C22H17Cl2FN2O4 |
| Smiles | O=C1C2=C(C(C3=CC=CC=C31)=O)OC(C4=C(C(O[C@H]5CN(CC5)C)=CC=C4F)Cl)=N2.Cl |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, and a total of 10 animals are to be administered, using a formulation of 
10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.Stock Solution Preparation:
Dissolve 2 mg of the compound in 100 μL DMSO to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
Preparation of the In Vivo Formulation:
1) Add 100 μL of the DMSO stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O and mix thoroughly until a homogeneous solution is obtained.
This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy OTUB1/USP8-IN-1 HCl | purchase OTUB1/USP8-IN-1 HCl | OTUB1/USP8-IN-1 HCl cost | order OTUB1/USP8-IN-1 HCl | OTUB1/USP8-IN-1 HCl chemical structure | OTUB1/USP8-IN-1 HCl in vivo | OTUB1/USP8-IN-1 HCl in vitro | OTUB1/USP8-IN-1 HCl formula | OTUB1/USP8-IN-1 HCl molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.